NCT07867600Recruiting
Low Dose Induction for Pediatric Acute Myeloid Leukemia Patients
Outcome of Pediatric Patients With Acute Myeloid Leukemia Treated According to SIOP Guidelines in Developing Countries
Source: ClinicalTrials.gov · Last updated 9 Oct 2026
Brief summary (registry, in English)
the standard induction treatment for pediatric acute myeloid leukemia has high early morbidity and mortality that jeopardize the outcome especially in developing countries. SIOP recommended lower dose induction synergistic G- CSF to minimize these unwanted toxicities. the study aimed at minimizing the toxicities during induction without jeopardizing the survival.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 33 (estimated)
- First submitted
- 28 Sept 2026
- Start date
- 28 Jul 2022
- Primary completion date
- Jul 2028
- Lead sponsor
- Azza Shibl Sayed
- Diseases
- Acute myeloid leukemia, Childhood cancers
- NCT number
- NCT07867600
What you commit to
- Study type: Interventional
- Planned participants: 33
- From 28 Jul 2022 to the primary completion date, Jul 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- AML secondary to myelodysplastic syndrome or prior chemotherapy.
Age
- Down syndrome with AML with age less than 4 years.
Other
- Children with promyelocytic leukemia
- death before treatment initiation
Who the study is looking for
- Denovo pediatric AML patients.
- equal or \<18 years old
Age in the registry: - to 18 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| South Egypt Cancer Institute, Assiut Univeristy Coordinator of this site? Confirm its status | Asyut | Egypt | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.